A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

  • SeaJ@lemm.ee
    link
    fedilink
    arrow-up
    5
    ·
    1 year ago

    Unfortunately people gain the weight back once they stop taking the drug if there is no lifestyle change which there often is not. A guy I know owned a good chunk of Sequence which essentially fast tracked access to Wegovy through telehealth and working with insurance companies. He was pushing to partner with a company that could provide that lifestyle change info so that people could keep off the weight when they stop using it. Weight Watchers bought them so hopefully they can help provide that lifestyle change.

    So far the side effects of Wegovy are fairly standard but it has only been around for 10 years and widely studied for an even shorter period since it has only been on the market for a couple years.

    • flicker@kbin.social
      link
      fedilink
      arrow-up
      1
      ·
      1 year ago

      I know that it’s a lifelong drug. I don’t care. I’ll take it. Especially because of the evened out crashes! Not having a sugar high or a sugar low is so wonderful for someone who has spent 37 years enslaved to snacks.